DJIA 17,032.43 1.29 0.01%
NASDAQ 4,523.70 4.80 0.11%
S&P 500 1,987.64 3.51 0.18%
market minute promo

Mallinckrodt plc (NYSE: MNK)

85.63 -0.15 (-0.17%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MNK $85.63 -0.17%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $85.50
Previous Close $85.78
Daily Range $84.91 - $86.05
52-Week Range $41.67 - $87.15
Market Cap $5.0B
P/E Ratio 77.28
Dividend (Yield) $0.00 (0.0%)
Volume 221,557
Average Daily Volume 3,926,678
Current FY EPS $4.31

Sector

Industry

Mallinckrodt plc (MNK) Description

Mallinckrodt plc Ordinary Shares Website: http://www.mallinckrodt.com/

News & Commentary

Why I'm Still Avoiding Questcor

A total of seven litigations against Questcor are currently underway. Two of them - the Retrophin litigation and USAO litigation - represent very serious threats to the H.P. Acthar business model.

NPS Pharmaceuticals' Natpara Gets Positive FDA Panel Vote - Analyst Blog

MNK January 2017 Options Begin Trading

Top Pharmaceutical Stock Highlights This Week’s Insider Selling

Can Mallinckrodt public limited (MNK) Keep the Earnings Streak Alive This Quarter? - Tale of the Tap

Can Mallinckrodt public limited (MNK) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape

Mylan to Acquire U.S. Rights to Arixtra for up to $300M - Analyst Blog

Actavis' Bystolic Combination Gets Negative FDA Panel Vote - Analyst Blog

Emergent BioSolutions Wins $29M Anthrax Vaccine Deal - Analyst Blog

Actavis' Antibiotic under FDA Review, Response in 1Q15 - Analyst Blog

Mallinckrodt (MNK) Shares March Higher, Can It Continue? - Tale of the Tape

Mallinckrodt (MNK) Shares March Higher, Can It Continue? - Tale of the Tape

Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint - Analyst Blog

See More MNK News...